Azathioprine as a Neuroprotective Agent in Experimental Traumatic Spinal Cord Injury.

Area of Science:

• Neuroscience
• Immunology
• Pharmacology

Background:

• Spinal cord trauma (SCT) triggers secondary injury cascades.
• Macrophage infiltration contributes significantly to secondary injury.
• Identifying agents to mitigate secondary injury is crucial.

Purpose of the Study:

• To investigate the neuroprotective potential of azathioprine (AZA).
• To evaluate AZA's effects on secondary injury mechanisms in a rat SCT model.
• To assess AZA's impact on macrophage activity and subsequent tissue damage.

Main Methods:

• Wistar rats underwent T8-10 laminectomy and T9 spinal cord trauma.
• Groups received azathioprine (4 mg/kg), saline, or no treatment post-trauma.
• Biochemical, immunohistochemical, and histopathological analyses were performed.
• Neurological function was assessed over 4 weeks.

Main Results:

• Azathioprine treatment significantly reduced apoptotic cells post-SCT.
• Animals treated with azathioprine exhibited improved neurological function.
• Reduced oxidative stress markers were observed in the azathioprine group.
• Histopathological analysis confirmed decreased secondary injury in AZA-treated rats.

Conclusions:

• Azathioprine demonstrates significant protective effects against secondary injury following spinal cord trauma.
• Azathioprine's mechanism involves inhibiting macrophage-mediated damage and reducing oxidative stress.
• This study supports azathioprine as a potential therapeutic agent for spinal cord injury.